cancers-logo

Journal Browser

Journal Browser

Tumor Suppressor Genes and Oncogenes: Genome-Wide Insights into Cancer Biology

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".

Deadline for manuscript submissions: 31 December 2026 | Viewed by 56

Special Issue Editor


E-Mail Website
Guest Editor
Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Interests: epigenetics; cancer; tumor suppressor; oncogenes

Special Issue Information

Dear Colleagues,

Tumor suppressor genes (TSGs) play an important role in cancer progression. In healthy cells, they regulate essential processes such as cell cycle regulation, DNA damage repair and cellular differentiation. However, when mutated or dysregulated, they give rise to aberrant molecular processes in cancer cells. Therefore, understanding their functions in oncogenesis is crucial for establishing cancer prevention and treatment strategies. In cancers, TSGs are primarily silenced through mutations, deletions, DNA methylation, histone modifications and post-transcriptional regulation, resulting in deregulated cellular checkpoints, DNA repair and apoptosis, thereby promoting cancer development. Studies have also shown that TSGs can function in a cell-type-specific manner, with their activity tightly regulated by the epigenetic landscape, transcriptional networks, and microenvironmental signals unique to each tissue.

At the same time, oncogenes—when activated or amplified—drive uncontrolled cell proliferation, survival, and metastasis, acting as powerful tumor-promoting factors. Thus, the interplay between tumor suppressor genes and oncogenes represents a fundamental axis of cancer biology.

Genome analysis using next-generation sequencing techniques has revolutionized our understanding of cancer biology, allowing researchers not only to study the entire genetic landscape of cancer cells but also pave the way for personalized medicine, where treatments are tailored to the genetic profiles of individual patients’ tumors. Techniques such as whole-genome sequencing, exome sequencing, and RNA sequencing enable the identification of tumor suppressor gene alterations, discovery of novel cancer-associated mutations, and development of targeted therapeutic strategies.

In this Special Issue, we highlight the role of and mechanisms behind the regulation of TSGs in cancer, emphasizing genome-wide studies and the systematic characterization of tumor suppressor gene alterations that are essential for advancing cancer diagnostics, prognosis, and personalized treatment strategies.

Dr. Meena Kanduri
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tumor suppressor genes
  • oncogenes
  • cancer
  • genome analysis
  • cancer mutations
  • DNA methylation
  • histone modification
  • cancer progression
  • oncogenesis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop